Lexpos News

The UK Health Security Agency (UKHSA) is undertaking a piece of work looking into the standards of practical and theoretical immunisation training. The work will help inform what more could be done to support healthcare staff in achieving and maintaining their skills and competences in this important area of clinical practice. UKHSA, NHS England and [...]

The post UKHSA immunisation training provider survey appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video discussing the structure of the Drug Tariff. In this video, we provide guidance on the different parts of Part VIII of the Drug Tariff, with a particular focus on Part VIIIA. In this video, Mitesh [...]

The post Funding & Reimbursement Shorts: Part VIII of the Drug Tariff appeared first on Community Pharmacy England.

Following the introduction of Category H in March 2026, the Department of Health and Social Care (DHSC) has announced that the following 8 products will move from Category C to Category H, effective from September 2026: Alfuzosin 10mg modified-release tablets Diclofenac 100mg suppositories Felodipine 10mg modified-release tablets Felodipine 2.5mg modified-release tablets Felodipine 5mg modified-release tablets [...]

The post Advance notice of 8 products moving to Category H in September 2026 appeared first on Community Pharmacy England.

NHS England have today (6th August 2026), published an updated version of the Hypertension Case-Finding Service (HCFS) specification. This revised version has been agreed by Community Pharmacy England and it contains a number of changes to the service requirements which were agreed as part of the 2025/26 CPCF negotiations. Download the revised service specification The [...]

The post Updated HCFS spec published appeared first on Community Pharmacy England.